Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation

Abstract

Heart transplantation is the gold standard therapy for patients diagnosed with end-stage heart failure. Despite the shortage of appropriate donor organs, the transplantation of hepatitis C-infected hearts is disputed. Previous research has shown that long-term results are controversial, and the risk of severe clinical infection should not be underestimated.